Delayed Pneumomediastinum and Subcutaneous Emphysema in Covid-19 Patients: Two Case Reports

authors:

avatar mahnaz moradi 1 , avatar leili yekefallah ORCID 2 , avatar fatemeh ghapanvari 1 , avatar Peyman Namdar 1 , *

Department of Critical Care Nursing, School of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin, Iran.
Metabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.

How To Cite moradi M, yekefallah L, ghapanvari F, Namdar P. Delayed Pneumomediastinum and Subcutaneous Emphysema in Covid-19 Patients: Two Case Reports. J Inflamm Dis. 2020;24(2):e156215. 

Abstract

Coronavirus Disease 2019 (COVID-19) is a severe respiratory disease initiated on December 2019. Genome sequence analysis shows that the pathogen is a complex beta-coronavirus RNA, known as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Spontaneous Pneumomediastinum and pneumothorax are rare clinical and radiological conditions associated with COVID-19. This study is case report of pneumomediastinum and subcutaneous emphysema in two patients with COVID-19, while investigating the clinical and paraclinical symptoms and the treatment process of two cases. Finding factors related to the severity of COVID-19 for improving the final outcome in patients is very important.